Drug evaluation: VX-702, a MAP kinase inhibitor for rheumatoid arthritis and acute coronary syndrome

Research output: Contribution to journalArticleResearchpeer-review

52 Citations (Scopus)
Original languageEnglish
Pages (from-to)1020 - 1025
Number of pages6
JournalCurrent Opinion in Investigational Drugs
Volume7
Issue number11
Publication statusPublished - 2006
Externally publishedYes

Cite this